Solutions designed for your unique needs
Comprehensive EDC
e-Patient Reported Outcomes
Unified Trial Builder
Mobile Data Capture
We manage complex trials across industries
Manage your clinical trials with clockwork precision
Winner of New Product or Service of the Year - Software - Healthcare Technology Solution at 2018 American Business Awards
Recognized with Top 10 "eclinical" solution 2017 award by Pharma Tech Outlook magazine.
Rated highest in overall satisfaction by
users in EDC service provider
performance survey.
Winner of "IT Products and Services for Healthcare”" at IT World Awards 2018
We are thought leaders with 100+ clients in the pharmaceuticals, CRO and medical devices industries.
Articles
RISK-BASED MONITORING- The next revolution in Clinical trials
Effective monitoring of clinical trials is a critical step while conducting quality studies and safeguarding subjects.
View more
Whitepaper
Patient centric trial design- The new success model
The clinical trial industry is going through a tectonic shift when it comes to increasing trial cost, time to market drugs and focus on patient empowerment. Yet, the toughest challenge in success of a clinical trial is to retain patients. In this whitepaper, we explore the various best practices of retaining patients and having a collaborative relationship with them.
View more
Case Studies
Lupin Implements Acceliant Platform for BA/BE studies
Acceliant developed a robust platform with a best-of-breed interface for clinical studies of Lupin.
View more
How You can Use Risk-Based Monitoring (RBM) to Boost Clinical Trial Outcomes
As the costs and complexity of clinical trials continue to rise substantially, study sponsors like you are increasingly spending more on monitoring...
Read More
Toward Faster and Cheaper Trials: Three Ways You can Improve Clinical Data Accuracy
Clinical trial complexity continues to grow with the number of procedures per protocol increasing significantly...
Read More
Building a Single, Connected Platform for EDC, Randomization and ePRO
Leading pharma regulators such as the U.S. FDA continue to impose, and enforce, strict compliance standards with regard to approval of new drugs. The U.S. watchdog’s strict vigil means that for every…
Read More
